Monitoring bioprocesses typically relies on real-time cell viability and metabolite data to assess bioreactor health. In contrast, protein titer — the primary indicator of process productivity — is often measured with offline high-performance liquid chromatography (HPLC), creating delays in process insight.
In this webinar, Sebastian Arevalo will discuss an at-line protein titer analysis approach that delivers near-instant, HPLC-quality results and how it can be implemented across development and manufacturing scales, from small-scale systems through pilot and large-scale bioreactors.
Topics to be covered:
- Combining real-time protein titer analysis with cell viability and metabolite measurements to achieve total process visibility
- Integrating and standardizing automated at-line titer monitoring across multiple bioreactor scales
- Real-world examples of applying at-line titer analysis to reduce delays and improve bioprocess productivity
Thursday, March 26th, 2026
11:00 AM – 12:00 PM ET
This webinar will be available to view live and on demand.
Speaker
Sebastian Arevalo
Vice President of Sales & Marketing
RedShiftBio
